Johnson & Johnson Medical Devices Companies announced that Biosense Webster Inc. has enrolled and treated the first patient in its STELLAR U.S. Investigational Device Exemption (IDE) study. The study will evaluate the safety and effectiveness of Heliostar Multi-electrode Radiofrequency (RF) Balloon Ablation Catheter in treating symptomatic drug refractory recurrent paroxysmal (intermittent) atrial fibrillation (AF). Up to 640 patients will be enrolled in as many as 40 clinical sites worldwide.

Healthcare technology company Livongo recently announced the launch of its Applied Health Signals product category, with technologies that combine data science, behavior enablement and clinical impact to help people with chronic conditions stay healthy. The new category includes a voice-enabled, at-home, cellular blood pressure monitoring system, free medication incentives for eligible members, and a number of new data science capabilities and partnerships.

Obstructive sleep apnea (OSA) and snoring may lead to earlier impairment of cardiac function in women than in men, according to a new study presented at the annual meeting of the Radiological Society of North America (RSNA). Moreover, the findings suggested that OSA may be vastly underdiagnosed among snorers.

November 27, 2018 – Zebra Medical Vision and Clalit Health Services announced the completion of a research project that ...

November 25, 2018 — During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America ...

New research in the December edition of the Journal of Vascular Surgery suggests significant increase in morbidities in obese patients after open surgery, but not after endovascular abdominal aortic aneurysm (AAA) repair.

Vivasure Medical Ltd. recently announced the European launch of the PerQseal closure device for large-bore transcatheter procedures.

November 16, 2018 — A research team led by scientists and doctors in Leicester and the Netherlands has shown that a ...